OTC & Nutraceuticals North America

North America NAD+ Supplements Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

North America NAD+ Supplements Market Industry Trends and Forecast to 2034: Segmented by (Ingredient, Form, Distribution Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

North America · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $250.5 Mn Placeholder estimate
Estimate 2025 $274.6 Mn 44.6% of the global market
Projected 2034 $626.6 Mn 128.2% Adds $352.0 Mn over 9 forecast years
CAGR 2025–2034 9.6% Faster than 88% of 82 OTC & Nutraceuticals markets here
Key players 5 Companies profiled
  • North America is 44.57% of the global market.
  • Among regions, the largest is North America (this report) at $274.6 Mn.
  • Fastest growing: Africa at 12.3% a year.
  • North America ranks 1st of 6 by size among regions.

Market size projection

North America

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$352.0 Mn total, 2026–2034

Year-by-year market size, 2024–2034
NAD+ Supplements Market market size by year, North America
YearMarket sizeChange that yearSince 2025
2024 (estimate) $250.5 Mn — —
2025 (base) $274.6 Mn +$24.1 Mn —
2026 (forecast) $301.0 Mn +$26.4 Mn +9.6%
2027 (forecast) $329.9 Mn +$28.9 Mn +20.1%
2028 (forecast) $361.5 Mn +$31.7 Mn +31.7%
2029 (forecast) $396.2 Mn +$34.7 Mn +44.3%
2030 (forecast) $434.3 Mn +$38.0 Mn +58.1%
2031 (forecast) $475.9 Mn +$41.7 Mn +73.3%
2032 (forecast) $521.6 Mn +$45.7 Mn +90%
2033 (forecast) $571.7 Mn +$50.1 Mn +108.2%
2034 (forecast) $626.6 Mn +$54.9 Mn +128.2%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

North America NAD+ Supplements Market Analysis at a glance
Market size, 2025$274.6 Mn placeholder estimate
Forecast, 2034$626.6 Mn placeholder estimate
Growth (CAGR), 2025–20349.6% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
Also calledNicotinamide Adenine Dinucleotide (NAD+) Supplements
SegmentsIngredient, form and distribution channel (see all)
Key playersChromaDex, Elysium Health, Thorne, Life Extension, Renue By Science (see all)
Active clinical trials7 in North AmericaSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in North America. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The North America NAD+ Supplements Market Analysis Executive Summary

NAD+ supplements, such as NMN and nicotinamide riboside, aim to raise levels of NAD+, a molecule linked to cell energy that falls with age.

Key segments of the NAD+ Supplements market include ingredient (Nicotinamide Riboside, NMN and NAD+ Direct) and form (Capsules, Powders and IV and Injections).

Bar chart: North America NAD+ Supplements market size, 2024–2034, placeholder estimates. $250.5 Mn in 2024, $274.6 Mn in 2025 and $626.6 Mn in 2034, 9.6% CAGR.
North America NAD+ Supplements market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

North America NAD+ Supplements Market Dynamics

Market Growth Drivers

An ageing population, longer life expectancy, rising interest in healthy ageing and new science on how the body ages are driving the NAD+ Supplements market. Older adults and their families are spending more on staying active and independent.

Opportunity

Preventive care, personalised plans based on biomarkers and home-based services give the NAD+ Supplements market room to grow, especially in fast-ageing countries in Asia and Europe.

Market Restraints

Limited clinical proof for some longevity products, high out-of-pocket costs, regulation that does not treat ageing as a disease and uneven access hold back the NAD+ Supplements market.

Competitive Landscape for NAD+ Supplements Market in North America

The NAD+ Supplements market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for NAD+ Supplements Market in North America

NAD+ Supplements in North America: rules and research

In the countries we cover here, medicines are approved by Health Canada (Canada)⁠[1] and FDA (US)⁠[2]. In the countries we cover here, supplement rules come from Health Canada (Canada)⁠[3] and FDA (US)⁠[4]. ClinicalTrials.gov lists 7 studies on NAD+ Supplements that are recruiting, active or about to start in North America.⁠[5]

[1] Health Canada. Checked 14 Nov 2026.

[2] US Food and Drug Administration. Checked 14 Nov 2026.

[3] Health Canada. Checked 14 Nov 2026.

[4] US Food and Drug Administration. Checked 14 Nov 2026.

[5] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in North America. Retrieved 12 Nov 2026.

Policy changes and Reimbursement scenario

Food and supplement rules, labelling and health-claim regulations govern NAD+ Supplements products. Authorities such as the US FDA, EFSA and national food safety bodies set what can be sold and claimed in North America.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in NAD+ Supplements right now, from free public sources.

Clinical trials

7 active trials in US and Canada

Recruiting, about to start, or running now. Counted across the 2 countries we report on in North America.

See every trial on ClinicalTrials.gov (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 16 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

NAD+ Supplements in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the NAD+ Supplements market in North America?
Placeholder estimate: about $274.6 Mn in 2025, rising to about $626.6 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the NAD+ Supplements market in North America growing?
Placeholder estimate: about 9.6% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the NAD+ Supplements market report cover?
The report splits the market by ingredient (Nicotinamide Riboside, NMN, NAD+ Direct, Combination Formulas), form (Capsules, Powders, IV and Injections) and distribution channel (Supermarkets and Hypermarkets, Pharmacies and Drug Stores, Online Retail, Specialty Stores).
Who are the key players in the NAD+ Supplements market?
Key players include ChromaDex, Elysium Health, Thorne, Life Extension and Renue By Science.
What is driving the NAD+ Supplements market?
An ageing population, longer life expectancy, rising interest in healthy ageing and new science on how the body ages are driving the NAD+ Supplements market. Older adults and their families are spending more on staying active and independent.
How many clinical trials on NAD+ Supplements are running in North America?
7 studies are recruiting, active or about to start in North America, counted across the 2 countries we report on there, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in North America. Retrieved 12 Nov 2026.
How much research is published on NAD+ Supplements?
PubMed lists 1,091 papers on NAD+ Supplements added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related OTC & Nutraceuticals reports in North America

See all

Related on geriatric and nutrition

See the topic